| Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
|---|
| 06/03/2009 | EP2064199A1 Diaryl ether derivatives and uses thereof |
| 06/03/2009 | CN101445469A Inhibitors of histone deacetylase |
| 06/03/2009 | CN101445468A Method for preparing para aminobenzoic acid quasi dipeptide ester and application thereof |
| 06/03/2009 | CN101444496A Compounds for the treatment of metabolic disorders |
| 06/03/2009 | CN100494250C Tree type molecule and its preparation method and use |
| 06/02/2009 | US7541485 chemical synthesis of 4(S)-[(Biphenyl-4-carbonyl)-amino]-4-[2-(4-fluoro-phenyl)-1,1-dimethyl-ethylcarbamoyl]-butyric acid; as aggrecanase inhibitors for treating articular cartilage in arthritic diseases, osteoarthritis; cancer, asthma, chronic obstructive pulmonary disease, atherosclerosis |
| 06/02/2009 | US7541465 Substituted 2-aminoacetamides and the use thereof |
| 05/28/2009 | WO2009066115A1 Colorimetric sensors for detection of the fluoride anion in solution and gel |
| 05/28/2009 | WO2009066072A2 Inhibitors of 17beta-hydroxysteroid dehydrogenase |
| 05/28/2009 | WO2009065406A2 Novel cyclic hydrocarbon compounds for the treatment of diseases |
| 05/28/2009 | WO2008068615A8 Crystalline forms of ( 3 s ) -3- [n- (n' - (2-tert-butylphenyl) oxamyl) alaninyl] amino-5- (2 ', 3 ', 5 ', 6 ' -tetrafluoro phenoxy) -4-0x0penta noic acid |
| 05/28/2009 | US20090137845 Novel 4-Dedimethylaminotetracycline derivatives |
| 05/28/2009 | US20090137805 N-phenyl-2-pyrimidine-amine derivatives |
| 05/28/2009 | US20090137681 Sirtuin Inhibiting Compounds |
| 05/28/2009 | US20090137679 ZN2+Chelating Motif-Tethered Short-Chain Fatty Acids as a Novel Class of Histone Deacetylase Inhibitors |
| 05/28/2009 | US20090137419 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 05/28/2009 | CA2706076A1 Novel cyclic hydrocarbon compounds for the treatment of diseases |
| 05/28/2009 | CA2703893A1 Compound |
| 05/27/2009 | EP1730141B1 Compounds for the treatment of diseases |
| 05/27/2009 | CN101440044A Fluoride-containing Gemini quaternary ammonium salt rare earth Lewis acid |
| 05/26/2009 | US7538182 conjugated by bridging molecules to proteins or polypeptides, reporter groups or cytotoxic agents; cancer |
| 05/26/2009 | US7538141 N-benzyl-2-{3-[2-({2-hydroxy-2-[5-hydroxy-6-(hydroxymethyl)pyridin-2-yl]ethyl}amino)-2-methylpropyl]phenyl}acetamide; beta 2 adrenergic receptors agonist; antiinflammatory, antiallergent, respiratory system disorder; side effect reduction; pharmacokinetics, potency, selectivity, duration of action |
| 05/26/2009 | US7538124 N-(p-(2-alpha-carboxybenzylamino)ethylamino)phenyl)p-(p-trifluoromethylphenyl)benzamide; hyperlipidemia; antiobesity and anti-type II diabetic agents; Microsomal triglyceride transfer protein inhibitors |
| 05/26/2009 | CA2474373C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substituent on the methyl useful as bradykinin antagonists |
| 05/26/2009 | CA2464223C Quarternary ammonium compounds and their use as antimuscarinic agents |
| 05/26/2009 | CA2403630C Methods for inhibiting angiogenesis and tumor growth |
| 05/26/2009 | CA2344058C Diaminopropionic acid derivatives |
| 05/22/2009 | WO2009064479A1 Polymorphic forms of aliskiren hemifumarate and process for preparation thereof |
| 05/22/2009 | WO2009062964A1 Novel solvate |
| 05/22/2009 | WO2009062963A1 Crystalline forms of tigecycline hydrochloride |
| 05/22/2009 | WO2009062402A1 Quinazolinone derivatives, the preparation methods and uses thereof |
| 05/22/2009 | CA2704536A1 Crystalline forms of tigecycline hydrochloride |
| 05/21/2009 | US20090131696 Reducing Tetracycline Resistance in Living Cells |
| 05/21/2009 | US20090131528 Salt |
| 05/21/2009 | US20090131487 calixarenes having acyclic isophthalic acid groups attached, used as target for platelet derived growth factors or vascular endothelial growth factors, angiogenesis inhibitors, antiproliferative, antitumor or anticarcinogenic agents |
| 05/21/2009 | US20090131473 2-(aryloxy) acetamide factor viia inhibitors useful as anticoagulants |
| 05/20/2009 | EP2059499A1 Processes of preparing asymmetric dinitrobenzamide mustard compounds, intermediate compounds useful therein and products obtained therefrom |
| 05/20/2009 | EP2059498A2 Treatment of cancer |
| 05/20/2009 | EP1562575B1 Fused cycloalkyl amides and acids and their therapeutic applications for the treatment of i.a. epilepsy |
| 05/20/2009 | CN101437788A Methods for reducing 7/9-nitrotetracycline derivatives |
| 05/20/2009 | CN101434561A Synthesis of 3-amino-4-chlorine-N-(5-chlorine-2-methyl phenyl) benzamide |
| 05/20/2009 | CN101434560A Alkyloxycarbonyl substituted abricycline derivative |
| 05/20/2009 | CN101434559A Preparation of aceglutamide |
| 05/20/2009 | CN100488943C Method for synthesizing theanine |
| 05/19/2009 | US7534915 Non-symmetrical gelling agent |
| 05/19/2009 | CA2211381C Compounds with growth hormone releasing properties |
| 05/14/2009 | WO2009060021A1 Contrast agents |
| 05/14/2009 | WO2009039361A3 Process for the preparation of (s)-2-(3-tert-butylureido)-3,3-dimethylbutanoic acid |
| 05/14/2009 | US20090124832 Oligoamine compounds and derivatives thereof for cancer therapy |
| 05/14/2009 | US20090124831 Lysine-d-amphetamine dimesylate; sustained release of amphetamine; Oral bioavailability of amphetamine maintained at useful doses, but bioavailability at higher dose substantially reduced; attention deficit disorder; hyperacctivity; narcolepsy; obesity; drug abuse, drug dependency |
| 05/14/2009 | US20090124583 7-N-substituted phenyl tetracycline compounds |
| 05/13/2009 | EP2057114A1 N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 05/13/2009 | CN101429141A Glycinamide alkyl oxanamide tetracycline derivants |
| 05/13/2009 | CN100487129C Clean production process of tetracycline antibiotics |
| 05/12/2009 | US7531676 Bipolar; cationic head linked to a hydrophobic backbone and a hydrophilic tail; capable of self assembly to form stable complexes in aqueous solutions; use for the delivery of bioactive substances such as nucleic acids to cells in vitro and especially in vivo |
| 05/12/2009 | US7531673 Preparation of amino acid amides |
| 05/12/2009 | US7531165 Hair conditioner; flexibility; smoothness |
| 05/07/2009 | WO2009057199A1 Retinoid prodrug compound |
| 05/07/2009 | WO2009056555A1 Contrast agents |
| 05/07/2009 | WO2009037707A3 N-phenyl anthranilic acid derivatives and uses thereof |
| 05/07/2009 | WO2009018065A3 Novel glucokinase activators and methods of using same |
| 05/07/2009 | WO2008066935A3 Crystalline forms of tigecycline and processes for preparation thereof |
| 05/07/2009 | WO2008010897A3 Process for making 3-substituted 2-amino-5-halobenzamides |
| 05/07/2009 | US20090118339 Lysine related derivatives as hiv aspartyl protease inhibitors |
| 05/07/2009 | US20090118199 Substituted acrylamide derivative and pharmaceutical composition comprising the same |
| 05/07/2009 | CA2703684A1 Retinoid prodrug compound |
| 05/06/2009 | EP2054377A1 Chemical compounds |
| 05/06/2009 | EP1465861B1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/05/2009 | US7528282 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 05/05/2009 | US7528152 synthetic analog of Hemiasterlin; anticarcinogenic agent; restenosis of blood vessels subject to traumas such as angioplasty and stenting; safe and effective, while retaining stability in biological media; exhibit low cytotoxicity to non-dividing normal cells |
| 04/30/2009 | WO2009054964A1 Alpha-aminoamide derivatives |
| 04/30/2009 | WO2009054916A2 Oligomer conjugates of lidocaine and its derivatives |
| 04/30/2009 | WO2009053277A1 Aspartyl protease inhibitors |
| 04/30/2009 | US20090112022 Preparation of iodixanol |
| 04/30/2009 | US20090111834 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| 04/30/2009 | US20090111183 Ketone Ligands for Modulating the Expression of Exogenous Genes Via An Ecdysone Receptor Complex |
| 04/29/2009 | CN101421231A Salt of aliskiren with sulfuric acid |
| 04/29/2009 | CN101421228A Preparation of chiral amides and amines |
| 04/29/2009 | CN100482638C N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors |
| 04/29/2009 | CN100482636C Process for preparation of substituted octanoyl amides |
| 04/29/2009 | CN100482635C Noval compounds, their use and preparation |
| 04/28/2009 | USRE40703 N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; differentiation-inducing activity, for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism, hematologic malignancy, a solid carcinoma |
| 04/28/2009 | US7524883 Eponemycin and epoxomicin analogs and uses thereof |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | US7524813 Selectively conjugated peptides and methods of making the same |
| 04/28/2009 | US7524486 Hair conditioner; flexibility; smoothness |
| 04/28/2009 | CA2259922C Calcium receptor active compounds |
| 04/23/2009 | WO2009052152A2 Tigecycline and methods of preparing intermediates |
| 04/23/2009 | WO2009050483A1 Cationic lipids |
| 04/23/2009 | WO2009028824A3 A novel cationic lipid, a preparation method of the same and a delivery system comprising the same |
| 04/23/2009 | WO2009013915A8 Inhibitor of plasminogen activator inhibitor-1 |
| 04/23/2009 | US20090105347 Thyronamine derivatives and analogs and methods of use thereof |
| 04/23/2009 | US20090105257 Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40 |
| 04/23/2009 | US20090105237 Cooling compounds |
| 04/23/2009 | US20090105223 Compound Having Activity Of Blocking NMDA Receptor Channel, and Pharmaceutical Agent Using The Same |
| 04/23/2009 | CA2702862A1 Cationic lipids |
| 04/22/2009 | EP2049493A2 Compounds suitable as modulators of hdl |
| 04/22/2009 | EP2049473A2 Substituted benzyl amine compounds |
| 04/22/2009 | CN100480248C Malonamide derivatives as gamma-secretase inhibitors |
| 04/22/2009 | CN100480234C N-(N-benzoyl-phenylalanyl)-phenylalanine dipeptide derivative, and preparing method and use thereof |